Apyx Medical CorporationAPYXNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank92
3Y CAGR+8.4%
5Y CAGR-5.5%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+8.4%/yr
vs +32.6%/yr prior
5Y CAGR
-5.5%/yr
Recent acceleration
Acceleration
-24.2pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 48.82% |
| Q3 2025 | 13.22% |
| Q2 2025 | 20.60% |
| Q1 2025 | -33.69% |
| Q4 2024 | 23.81% |
| Q3 2024 | -5.45% |
| Q2 2024 | 18.60% |
| Q1 2024 | -30.13% |
| Q4 2023 | 22.43% |
| Q3 2023 | -11.74% |
| Q2 2023 | 11.75% |
| Q1 2023 | -3.72% |
| Q4 2022 | 38.37% |
| Q3 2022 | -11.45% |
| Q2 2022 | -17.62% |
| Q1 2022 | -25.74% |
| Q4 2021 | 42.20% |
| Q3 2021 | 5.41% |
| Q2 2021 | 29.94% |
| Q1 2021 | -24.65% |
| Q4 2020 | 64.85% |
| Q3 2020 | 61.87% |
| Q2 2020 | -14.03% |
| Q1 2020 | -40.95% |
| Q4 2019 | 11.72% |
| Q3 2019 | 15.33% |
| Q2 2019 | 12.79% |
| Q1 2019 | -1.74% |
| Q4 2018 | 61.38% |
| Q3 2018 | -68.00% |
| Q2 2018 | 15.72% |
| Q1 2018 | -12.62% |
| Q4 2017 | 21.41% |
| Q3 2017 | -4.61% |
| Q2 2017 | 16.81% |
| Q1 2017 | -11.64% |
| Q4 2016 | -5.65% |
| Q3 2016 | 8.26% |
| Q2 2016 | 19.55% |
| Q1 2016 | -6.26% |